Dalit Hazan
Chief Tech/Sci/R&D Officer bij POLYPID LTD.
Vermogen: - $ op 31-03-2024
Profiel
Dalit Hazan is currently working as the EVP-Regulatory Affairs, Research & Development at PolyPid Ltd.
She started this position in 2022.
Prior to her current role, she worked at Teva Pharmaceutical Industries Ltd.
from 2007 to 2016 as the Head-Global Regulatory Affairs.
Before that, she was the Manager-Regulatory Affairs at Dexcel Pharma Ltd.
from 1998 to 2007.
Ms. Hazan holds an MBA from Bar-Ilan University and has completed undergraduate and graduate studies at Sackler Faculty of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
POLYPID LTD.
-.--% | 06-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Dalit Hazan
| Bedrijven | Functie | Begin |
|---|---|---|
| POLYPID LTD. | Chief Tech/Sci/R&D Officer | 01-03-2022 |
Eerdere bekende functies van Dalit Hazan
| Bedrijven | Functie | Einde |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | General Counsel | 01-04-2016 |
Dexcel Pharma Ltd.
 Dexcel Pharma Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Ltd. develop, manufacture and market value-added branded and generic pharmaceuticals. The company was founded by Dan Oren in 1968 and is headquartered in Northamptonshire, the United Kingdom. | General Counsel | 01-07-2007 |
Opleiding van Dalit Hazan
| Bar-Ilan University | Masters Business Admin |
| Sackler Faculty of Medicine | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| POLYPID LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Dexcel Pharma Ltd.
Dexcel Pharma Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Ltd. develop, manufacture and market value-added branded and generic pharmaceuticals. The company was founded by Dan Oren in 1968 and is headquartered in Northamptonshire, the United Kingdom. | Health Technology |
